Boehringer Ingelheim is proud to offer a 2-year CDMA Fellowship Program designed to provide pharmacists with broad U.S. Medical Affairs exposure. The program will allow Fellows to develop the competencies necessary to engage in comprehensive Medical activities. Fellows will be based at Boehringer Ingelheim’s U.S. headquarters in Ridgefield, CT and will complete 9-months each in Medical Strategy and Scientific Communications. Additionally, Fellows will have the chance to complete 6 months of rotational experiences in one or more areas outside of CDMA through which they will gain an understanding of the broad range of opportunities available within the pharmaceutical industry.
As part of their experience, Fellows will:
Actively participate in therapeutic area (TA) specific development, execution, and strategic alignment of U.S. Medical and brand tactics
Develop cross-functional project management skills by partnering with internal and external stakeholders to support U.S. Medical Information and Publication teams
Gain crucial experience in planning and executing advisory board meetings, engaging Key External Experts (KEEs),developing educational materials, training internal Medical team members, disseminating data from scientific manuscripts, congress, etc.
Improve interpersonal and verbal communication skills via customer-facing activities including staffing medical information booths at national conferences and interacting with Field-Based Medicine teams to identify areas of unmet medical needs
Participate in the medical review of promotional and non-promotional materials as part of a multidisciplinary team (e.g., Human Pharma Review Committees).
As part of their experience, Fellows will:
Provide complete, accurate, balanced and referenced responses to medical information inquiries from healthcare professionals and patients, both verbally and in writing
Contribute to the development of managed care formulary dossiers and maintain a comprehensive product response database, as well as a compendium of key product data for managed care, hospital, and Medicaid formulary committees
Conduct product trainings that tailor the content to the needs of diverse audiences (e.g. Call Center personnel, field-based representatives, etc.)
Participate in the medical review of promotional and non-promotional materials as part of a multidisciplinary team (e.g., Grant Review Committees, Human Pharma Review Committees)
Contribute to the strategy and development of publications for major journal manuscripts and Congress posters and presentations
Collaborate with Medical Strategy for the review of Investigator-Initiated Studies (IIS) and Independent Medical Education proposals.
The Fellow will have an opportunity to participate in multiple rotations with other Boehringer Ingelheim departments. Potential electives include, but are not limited to:
Health Economics and Outcomes Research
Other rotations can be arranged based on availability and interest of the Fellow.
As part of the Fellowship program, Fellows will gain numerous development opportunities by:
Leading and executing a longitudinal research project to improve medical processes and presenting the outcomes at a national medical conference
Enhancing leadership and management skills by precepting Advanced Pharmacy Practice Experience (APPE) students
Gaining an understanding of corporate structure, regulatory considerations and the drug development process
Networking across Boehringer Ingelheim to learn about various opportunities in the pharmaceutical industry and participating in skills-based volunteerism.
Must be legally authorized to work in the United States without restriction
Must be willing to submit to a background investigation, including verification of your past employment, criminal history, and educational background
Must be willing to take a drug test and post-offer physical (if required)
Must be 18 years of age or older.
Additional Salary Information: The Fellow will receive a competitive stipend and benefits package.
Boehringer Ingelheim is focused on science that leads to more health for our patients and their families. The discovery and development of innovative medicines is fundamental to our continued growth and success. Our blueprint for innovation is tailored to accelerate the delivery of breakthrough medicines to the patients we serve by integrating research, pre-clinical and early clinical development,... translational medicine, and external partnering functions. This fusion of expertise combined with a dynamic research approach and an increased emphasis on external collaborations means we can effectively incubate the most creative ideas and be among the pioneers in emerging fields of medicine.